Genus reprimanded for ‘sexual and titillating’ advert
August 15, 2012Sales and Marketing ABPI, Genus, PMCPA, breach, eczema
Genus has been found in breach of the ABPI Code after using a sexually charged image for the promotion of …
Smoke and fire in J&J Code breach
August 15, 2012Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer
Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …
MSD joins forces with PatientsLikeMe for psoriasis
August 14, 2012Medical Communications MSD, Novartis, PatientsLikeMe, digital, psoriasis
MSD has teamed up with the online patient community site ‘PatientsLikeMe’ to gauge the impact of psoriasis on patients, whilst …
Elan to spin off drug discovery arm
August 14, 2012Research and Development, Sales and Marketing Elan, Neotype Biosciences, Tysabri, multiple sclerosis
Elan Corporation is to spin off its drug discovery arm Neotype Biosciences to create a separate, quoted company by the …
New Avastin data could be bad news for Lucentis
August 14, 2012Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD
The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …
China sets February 2013 deadline for excipient regulations
August 14, 2012Manufacturing and Production China, IPEC, SFDA, Taylor
China has moved swiftly ahead with new regulations governing quality rules for pharmaceutical excipients, including new requirements for pharma firms …
Astellas Pharma Europe appoints new senior director
August 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Susan Wood
Astellas Pharma Europe has appointed Dr Susan Wood as senior director, Market Access. Formerly senior brand director of APEL’s Pain Management …
Acino plant opens to serve Bayer contraceptive patch needs
August 14, 2012Manufacturing and Production Acino, Bayer, R&D, Swiss, contraceptive
Acino has officially opened its new manufacturing facility for transdermal patch products in Miesbach, Germany, which it says makes it …
Novartis pledges to maintain R&D presence in Horsham
August 14, 2012Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts
Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …
Pfizer pays $250m for OTC Nexium rights
August 14, 2012Sales and Marketing AstraZeneca, EMA, FDA, Nexium, OTC, Pfizer
Pfizer will pay $250 million to AstraZeneca in order to gain the rights to sell an over-the-counter form of the …
Pharma manufacturing news in brief
August 14, 2012Manufacturing and Production Advanced Bioscience, Almac, Amneal, Cipla, Isis, Sanofi Pasteur
Cipla opening three new API plants as Indian trade delegations forges closer ties with Sri Lanka; plus facility updates from …
Amgen unveils plan to close Epogen plant
August 14, 2012Manufacturing and Production Amgen, Epogen, cuts, omontys
Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …
De Facto in management buy out
August 14, 2012Medical Communications Chime Communications, De Facto Communications
Healthcare and life sciences communications specialist De Facto Communications has completed a management buyout of the business from Chime Communications.The …
WuXi continues strong growth
August 14, 2012Manufacturing and Production China, WuXi
Chinese contract research firm Wuxi saw its revenue grow strongly in the second quarter, with its laboratory services playing a …
Avastin sees success in brain cancer trial
August 13, 2012Research and Development, Sales and Marketing R&D, avastin, brain cancer
A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …
Torisel-Avastin combo fails in kidney cancer
August 13, 2012Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc
Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …
Lucentis gains new licence in the US
August 13, 2012Sales and Marketing Eylea, FDA, Lucentis, approval, avastin, wet AMD
Roche’s eye drug Lucentis has gained a new licence in the US to treat diabetic macular oedema. The FDA has …
Contract research news in brief
August 10, 2012Research and Development Accenture, Charles River Labs, ICON, Octagon Research Solutions, Phlexglobal, Quanticate, Verum
ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, Accenture/Octagon and Quanticate.
Merck Serono says dispute over Geneva closure is resolved
August 10, 2012Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts
Merck Serono says it has reached agreement with groups representing workers affected by the closure and downsizing of sites in …
FDA approves leukaemia drug Marqibo
August 10, 2012Sales and Marketing FDA, Marqibo, Talon Therapeutics, lilly
The Food and Drug Administration has given the green light for Talon Therapeutics’ Marqibo to combat a rare form of …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
